Vivani Medical, Inc. Financial Ratios
VANI|FY2017 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2017 SEC 10-K data.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2017)
Return on Equity
-98.8%
Profit Margin
-223.7%
Net Income / Revenue
Asset Turnover
0.62
Revenue / Total Assets
Equity Multiplier
0.72
Total Assets / Equity
Composite: -98.8% (reported: -98.8%)
Profitability
Liquidity
Current Ratio
1.99
Quick Ratio
1.58
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.62
Inventory Turnover
1.96
Days Sales Outstanding
75 days
As of FY2017 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+3.4%
+111.1pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.